Blood infection study to understand heart valve infections
Part of Heart & circulation, Infections clinical trials.
This study collects blood samples and medical information from patients with certain bloodstream infections to better understand why some develop a heart valve infection. The goal is to find out why some people get this complication and how to predict it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You are hospitalized with a blood infection caused by Enterococcus faecalis or another bacteria, and the source is not obvious
- You have started antibiotics less than 48 hours ago (or will start very soon)
- You are able to understand and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving iron and a blood-boosting medicine (EPO) helps patients with bacterial heart valve infections who have low red blood cells. The goal is to see if it speeds recovery and improves how patients feel.
This study looks at people who have heart surgery to treat a serious heart infection called infective endocarditis. It helps doctors learn more about how these surgeries work and what affects recovery.
This trial tests whether a treatment without rifampin works as well as one with rifampin for a type of heart valve infection caused by staph bacteria. It aims to find a simpler and safer option for patients with an infected artificial heart valve.
This is an observational study that follows people with confirmed infective endocarditis (a serious infection of the heart lining or heart valves). It may help doctors better understand the illness and improve care.
This study gathers information from patients with a heart infection called endocarditis to help doctors better understand and treat the condition. Anyone aged 16 or older with confirmed or suspected endocarditis who is being treated at Barts Heart Centre may be able to join.
This study looks at blood and other lab test results (“biomarkers”) to better predict what may happen to people with infective endocarditis, a serious infection of the heart lining or heart valves. Your information may help doctors estimate risk and choose care more safely and effectively.
Hear when a new Infective Endocarditis (IE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.